PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients

被引：0

作者：

P Lu

J Hsu

C Keane

S Fettner

J Wang

N Ruperto

O Harari

HI Brunner

F De Benedetti

机构：

[1] Nutley,Roche

[2] Roche,undefined

[3] PRINTO,undefined

[4] PRCSG,undefined

[5] IRCCS Ospedale Ped Bambino Gesú,undefined

来源：

Pediatric Rheumatology | / 11卷 / Suppl 2期

关键词：

Juvenile Idiopathic Arthritis; Tocilizumab; Polyarticular Juvenile Idiopathic Arthritis; Linear Clearance; Poppk Analysis;

D O I：

10.1186/1546-0096-11-S2-P171

中图分类号：

学科分类号：

摘要：

引用

共 26 条

[21] Performance of different sets of criteria for clinical response evaluation in a non-selected cohort of juvenile idiopathic arthritis (jia) patients
Gutierrez, Raul
Burgos Vargas, Ruben
[J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S716 - S716
[22] PReS-FINAL-2072: How does the management of enthesitis related arthritis differ from other sub-types of juvenile idiopathic arthritis? A retrospective study of jia at an adolescent rheumatology centre
M Choudhury
D Sen
J Ioannou
[J]. Pediatric Rheumatology, 11 (Suppl 2)
[23] PReS-FINAL-2071: Anti-type II collagen antibodies, anti-CCP, IgA-RF and IgM-RF are associated with joint damage eight years after onset of juvenile idiopathic arthritis (JIA)
L Berntson
K Aalto
A Fasth
T Herlin
S Nielsen
E Nordal
M Rygg
J Rönnelid
[J]. Pediatric Rheumatology, 11 (Suppl 2)
[24] PReS-FINAL-2166: Long-term safety and effectiveness of anti-interleukin-6 receptor monoclonal antibody, tocilizumab, in patients with systemic juvenile idiopathic arthritis in Japan
S Yokota
T Nozawa
T Kanetaka
K Yamazaki
T Sato
N Sakurai
M Kikuchi
[J]. Pediatric Rheumatology, 11 (Suppl 2)
[25] ELEVATION OF SPECIFIC IGE ANTI ASCARIS LUMBRICOIDES(AL) IS ASSOCIATED WITH A TYPE 1 DIABETES (T1D) BUT NOT JUVENILE IDIOPATHIC ARTHRITIS (JIA) DIAGNOSTICS IN COLOMBIAN CHILDREN PATIENTS
Garavito, G.
Malagoni, C.
Mendoza, D. L.
Moreno, S.
Navarro, E. A.
Iglesias, A.
Olmos, C.
Del Toro, K.
Ordonez, J.
Egea, E.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A45 - A45
[26] Body Surface Area-Based Dosing Approach Produced Comparable Golimumab Exposure Across Different Age Ranges After Subcutaneous Administration Of Golimumab In Pediatric Patients With Juvenile Idiopathic Arthritis
Leu, Jocelyn H.
Mendelsohn, Alan M.
Ford, Joyce
Davis, Hugh M.
Xu, Zhenhua
[J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S123 - S123

← 1 2 3 →